Freshpet (FRPT) and Petiq (PETQ) Head to Head Analysis

Freshpet (NASDAQ: FRPT) and Petiq (NASDAQ:PETQ) are both small-cap consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation and analyst recommendations.

Analyst Recommendations

This is a summary of current recommendations and price targets for Freshpet and Petiq, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Freshpet 0 3 3 0 2.50
Petiq 0 1 5 0 2.83

Freshpet currently has a consensus price target of $15.75, indicating a potential downside of 1.25%. Petiq has a consensus price target of $27.00, indicating a potential upside of 6.93%. Given Petiq’s stronger consensus rating and higher probable upside, analysts plainly believe Petiq is more favorable than Freshpet.

Profitability

This table compares Freshpet and Petiq’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Freshpet -2.57% -3.44% -2.90%
Petiq N/A N/A N/A

Valuation & Earnings

This table compares Freshpet and Petiq’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Freshpet $143.08 million 3.54 $8.06 million ($0.11) -145.00
Petiq N/A N/A N/A N/A N/A

Freshpet has higher revenue and earnings than Petiq.

Institutional and Insider Ownership

66.8% of Freshpet shares are held by institutional investors. 6.8% of Freshpet shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Petiq beats Freshpet on 6 of the 9 factors compared between the two stocks.

Freshpet Company Profile

Freshpet, Inc. is a manufacturer of fresh, refrigerated pet food distributed across North America. The Company operates in the segment of manufacturing, marketing and distribution of pet food and pet treats for dogs and cats. The Company’s products consist of dog food, cat food, and dog and cat treats. Its recipes include real, fresh meat and varying combinations of vegetables, leafy greens and anti-oxidant rich fruits, without the use of preservatives, additives or artificial ingredients. All of its products are sold under the Freshpet brand name, with ingredients, packaging and labeling customized by class of retail. It also offers fresh treats across all classes of retail under the Dognation and Dog Joy labels. The Company’s products are available in various forms, including slice and serve rolls, bagged meals and tubs. All of the Company’s products are manufactured in the United States.

Petiq Company Profile

PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.

Receive News & Ratings for Freshpet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Freshpet Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply